Estee Lauder Companies Inc. Total Cost of Revenue decreased by 11.9% to $876.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $889.00M to $876.00M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a -0.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $986.00M | $1.06B | $1.22B | $994.00M | $1.03B | $1.02B | $1.22B | $1.16B | $1.16B | $1.07B | $1.15B | $1.11B | $1.09B | $928.00M | $957.00M | $889.00M | $955.00M | $927.00M | $994.00M | $876.00M |
| QoQ Change | — | +7.2% | +15.7% | -18.7% | +3.7% | -0.8% | +19.2% | -4.9% | +0.3% | -8.0% | +7.9% | -4.1% | -1.3% | -15.1% | +3.1% | -7.1% | +7.4% | -2.9% | +7.2% | -11.9% |
| YoY Change | — | — | — | — | +4.6% | -3.2% | -0.3% | +16.6% | +12.8% | +4.6% | -5.3% | -4.5% | -6.0% | -13.3% | -17.1% | -19.7% | -12.6% | -0.1% | +3.9% | -1.5% |